Status:
COMPLETED
The Influence of Reducing Diets on Changes in Thyroid Parameters in Obese Women With Hashimoto's Disease
Lead Sponsor:
Medical University of Bialystok
Conditions:
Hashimoto Disease
Obesity
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Hashimoto's disease is listed among the most common endocrine causes of obesity. As treatment of obesity in women with Hashimoto's disease is frequently unsuccessful, the aim of this study was to eval...
Eligibility Criteria
Inclusion
- Diagnosed with Hashimoto's disease
- BMI over 30 kg/m2
- Taking the L-thyroxine, 200 mcg of 1-selenomethionine/day, and 30 mg of zinc gluconate/day throughout the study period
Exclusion
- \---
Key Trial Info
Start Date :
March 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04752202
Start Date
March 29 2019
End Date
October 31 2019
Last Update
February 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dietetic and Clinical Nutrition; Medical University of Bialystok
Bialystok, Poland, 15-054